REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/02/2026
Back to search
Official data from USPTO
EHP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
02/03/2026
Classification
Registered
Trademark type
Word
Nice classes
10, 42, 44
Filing date
05/15/2019
Registration date
02/02/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2021
Last transaction
02/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
01
Owner location
DE
Examiner
FALK, JONATHAN ROBERT
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
D. S. (pessoa física)
Representatives
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus for treating tumors of the human or animal body; apparatus for purifying the blood during surgical or therapeutic procedures; medical apparatus and instrumentsbloodblood purificationtoxinpesticideparasitedrugpoisonheavy metalbacteria and virusimmunopathogenic agentbilirubinbeta 2 microglobulin filters; medical apparatus and instrumentsdrug deliverybloodfluidperistaticmembranecentrifugal pumps; medical apparatus and instrumentsadsorbers for blood purification and removal of toxinspesticidesparasitesdrugspoisonheavy metalbacteriavirusesimmunopathogenic agentbilirubinbeta 2 microglobulin from the blood; medical apparatus and instrumentsheat exchangersoxygenatorsdevices for ozone productionozone devices for treatment of bloodozone devices for the killing and removal of bacteriavirusesparasitestube systems comprised of tubes for passing blood and fluidshemoperfusion devicesblood purification devicesdevices for inducing hyperthermiadevices for thermotherapyblood perfusion devicesperfusion devices for the treatment of bloodperfusion cutlery for surgery; surgical apparatus and instruments; diagnostic and therapeutic equipment in the pharmaceuticalmedical and veterinary fieldsequipment for blood gas analysisdevices for measuring blood coagulationdevices for measuring oxygen saturationdevices for measuring body temperaturehemoperfusion devices for the treatment of bloodclinical laboratory analyzers for blood and blood component analysischemistry analyzers for blood and blood component analysisautomated sample handling equipment for testing purposesimmunohematology analyzer for blood and blood component analysisapparatus for blood screeningblood typingdetection of assays associated with blood screening and blood typing used in the transfusion medicine market; medical instruments for the extracorporeal destruction of cancer cellsheat exchangersdevices for inducing hyperthermiadevices for thermotherapy; medical instruments for the extracorporeal purification of the blood and supply of natural or chemical substances to the bodyfilterpumpsadsorbersinfusion equipment for drug deliverypain therapyblood purificationblood perfusion; medical instrumentspatient cradle equipment suitable for use in hyperthermiathermotherapy or thermometry treatmentscontrol devicescontrol systemscontroller such as temperature controller; medical apparatusequipment and instruments for chemotherapy and electrochemical tumor therapy; medical apparatushyperthermia systemsheat exchangersdevices for inducing hyperthermiadevices for thermotherapy
Class 42
Advisory or additive services relating to therapy for the treatment of tumors of the human or animal bodynamely development of medical imaging methodslaboratory analyseschemosensitivity testinggene analyses for medical research or diagnostic purposes; advisory or additive services relating to therapy for the purification of blood in surgical or theoretic proceduresnamely imaging methodslaboratory analysesmedical laboratory chemosensitivity testinggene analyses for medical research purposestherapy monitoring for medical research purposestherapy setting for medical research purposestherapy adjustment for medical research purposes; services provided by a supplier of medical apparatus and instrumentsnamely technical advice relating to the operation of medical equipment and instruments adapted to the customer's specific applicationsfunctional analysisdevice adjustment in the nature of calibrationquality controlcalibration of medical equipment and instruments; development and research services relating to new products for third parties in the field of hemoperfusion therapy or hyperthermiatherapy based on hyperthermiaoxygen supply and adsorption of molecules from blood; biological research; research in the field of chemistry; research in the field of hemoperfusion therapy or hyperthermiatherapy based on hyperthermiaoxygen supply and adsorption of molecules from blood
Class 44
Medical services in the field of oncology; medical services for the treatment of diseases of the human or animal body; provision of heat therapy for treating tumors in human or animalshyperthermiahemoperfusion therapy; blood purification services for surgical or therapeutic procedures
Publications
History of USPTO decisions and trademark events.
38 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/06/2021
FIMP
FINAL DISPOSITION PROCESSED
05/06/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/02/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/12/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/17/2020
PUBO
PUBLISHED FOR OPPOSITION
11/17/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/09/2020
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
08/06/2020
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
08/06/2020
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
08/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/07/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2020
GNFR
FINAL REFUSAL E-MAILED
04/14/2020
CNFR
FINAL REFUSAL WRITTEN
04/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2020
RFNT
REFUSAL PROCESSED BY IB
10/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2019
RFRR
REFUSAL PROCESSED BY MPU
09/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/14/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/13/2019
CNRT
NON-FINAL ACTION WRITTEN
09/12/2019
DOCK
ASSIGNED TO EXAMINER
09/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/29/2019
Continuous trademark protection
Get notified about every new filing that threatens EHP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.